Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
CPT: Pharmacometrics & Systems Pharmacology|January 31, 2014
Incorporating Target Shedding Into a Minimal PBPK-TMDD Model for Monoclonal AntibodiesL Li, I Gardner, R Rose, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 14, 2014
Interaction Between Domperidone and Ketoconazole: Toward Prediction of Consequent QTc Prolongation Using Purely In Vitro InformationH Mishra, S Polak, M Jamei, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 2, 2019
VIVD: Virtual in vitro distribution model for the mechanistic prediction of intracellular concentrations of chemicals in in vitro toxicity assaysC Fisher, S Siméon, M Jamei, et al.
Current Drug Metabolism|June 13, 2009
Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 inductionL M Almond, J Yang, M Jamei, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2014
Application of a Physiologically Based Pharmacokinetic Model to Predict OATP1B1-Related Variability in Pharmacodynamics of RosuvastatinR H Rose, S Neuhoff, K Abduljalil, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 9, 2018
Development and applications of a physiologically-based model of paediatric oral drug absorptionT N Johnson, J J Bonner, G T Tucker, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 5, 2011
Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: impact of inactivation parameters and enzyme turnoverK Rowland Yeo, R L Walsky, M Jamei, et al.
Pageof 2